Coronary Artery Disease

Coronary artery disease is the most common type of heart disease and the leading cause of death worldwide. It occurs when the arteries that supply blood to the heart become narrowed or blocked by a buildup of "plaque" - cholesterol or other fatty deposits that build on the inner wall of the artery.

What is Coronary Artery Disease?

Coronary artery disease is another term used for atherosclerotic heart disease, a condition caused by a narrowing, hardening and furring of the walls of the coronary arteries.

Coronary Artery Disease Pathophysiology

Coronary Artery Disease Angina

Coronary Artery Disease Risk Factors

Coronary Artery Disease Prevention

Coronary Artery Disease Preventive Diets

Coronary Artery Disease and Aspirin

Coronary Artery Disease and Omega-3 Fatty Acids

Coronary Artery Disease Characteristics

Coronary Artery Disease Treatment

Latest Coronary Artery Disease News and Research

GlobalData: NEJM study further confirms link between heart disease and death from COVID-19

Following the recent publication of a study in the New England Journal of Medicine that further confirms the elevated risk of in-hospital death amongst COVID-19 patients with concomitant cardiovascular disease;

26 Jun 2020

Study explores ways to prevent the accumulation of visceral fat among the elderly

In a new publication from Cardiovascular Innovations and Applications, Israel Oluwasegun Ayenigbara from University of Ibadan, Ibadan, Nigeria considers accumulation of visceral fat and preventive measures among the elderly.

24 Jun 2020

Tracking patients' medical records over time reveals more about diseases

Electronic health records contain important information about patients' health outlook and the care they receive, but the records are not always precise.

18 Jun 2020

ACE2 and pattern recognition receptor genes increase with age

A recent study by researchers in California and published on the preprint server bioRxiv* in June 2020 shows that advancing age is associated with increased expression of pattern recognition receptor (PRR) genes and ACE2 receptors, possibly accounting in part for the increased severity of the disease in older adults.

17 Jun 2020

Heart damage among hospitalized COVID-19 patients linked to higher risk of mortality

Mount Sinai researchers have found that myocardial injury (heart damage) is prevalent among patients hospitalized with COVID-19 and is associated with higher risk of mortality.

8 Jun 2020

Polygenic risk scores may improve clinical assessment of patients with elevated heart attack risk

Genetic variants have been linked with a higher risk of having a heart attack, permitting the calculation of "polygenic risk scores" (PRS) that quantify patients' inherited susceptibility based on the number of variants they have.

2 Jun 2020

No specific COVID-19-linked lesions found despite extensive organ injury

A recent paper published online on the preprint server medRxiv in May 2020 reports autopsy results on COVID-19 patients. The paper concludes that there were no specific hallmark lesions of COVID-19 in any of the many organs found to be injured by the infection in patients who died of the disease.

1 Jun 2020

How comorbidities affect SARS-CoV-2 viral entry

Almost from the start of the current COVID-19 pandemic, it has become clear that individuals suffering from other medical conditions like diabetes, cardiovascular disease, and lung disease are far more likely to contract the infection and to have a poorer outcome.

28 May 2020

PCR and CRF partner to deliver practical education in virtual format

PCR and CRF are pleased to announce the creation of virtual Partners in Learning sessions that will be broadcast during the PCR e-Course (June 25-27, 2020) and CRF’s TVT Connect meeting (June 18-28, 2020).

28 May 2020

Study: Women less likely to have cardiovascular disease, and die of it, than men

A huge study of more than 160,000 people in 21 countries has found that women are less likely to have cardiovascular disease, and die of it, than men.

20 May 2020

SCAI publishes position statement addressing optimal PCI treatment for complex CAD

The Society for Cardiovascular Angiography and Interventions has published a position statement addressing optimal percutaneous coronary intervention treatment of patients with complex coronary artery disease.

14 May 2020

SCAI releases recommendations for managing patients with out-of-hospital cardiac arrest

The Society for Cardiovascular Angiography and Interventions has released an expert consensus statement describing recommendations for the management of patients with out-of-hospital cardiac arrest.

14 May 2020

Study shows why older individuals are vulnerable to COVID-19

A group of tiny RNA that should attack the virus causing COVID-19 when it tries to infect the body are diminished with age and chronic health problems, a decrease that likely helps explain why older individuals and those with preexisting medical conditions are vulnerable populations, investigators report.

13 May 2020

Study provides indications and techniques of lower extremity revascularization

Lower extremity artery disease is a leading cause of morbidity and mortality worldwide, affecting hundreds of millions of people.

7 May 2020

Is ACEI, ARB use linked to testing positive for COVID-19?

A new study published in the prestigious journal JAMA Cardiology in May 2020 reports that there is no association between the use of ACEIs/ARBs and testing positive for COVID-19. This supports current medical advice to continue using these drugs as indicated irrespective of the ongoing pandemic but indicates the need for more research to rule out any additional risk of severe illness due to these agents.

6 May 2020

AHA emphasizes the importance of managing cardiovascular disease during pregnancy

A new statement issued today by the American Heart Association emphasizes the importance of taking a multidisciplinary approach to the management of cardiovascular disease during pregnancy and outlines heart care before, during and after pregnancy.

5 May 2020

New clinical trial to assess whether hypertension drug may reduce COVID-19 severity

Researchers at University of California San Diego School of Medicine have launched a clinical trial to investigate whether a drug approved for treating high blood pressure, heart failure and diabetic kidney disease might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.

30 Apr 2020

Apple Watch ECG app may detect coronary ischemia

Digitization can do a lot in medicine, even save lives. This is shown by the specific case of an 80-year-old patient in Mainz.

30 Apr 2020

Free clinics try to fill gaps as COVID sweeps away job-based insurance

The 55-year-old man, who moved to Tupelo from Georgia to take care of his dying father nearly four years ago, found manufacturing work that came with health insurance.

30 Apr 2020

COVID-19 and immunodeficiency

COVID-19 disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a highly infectious disease. As of today, over 170,000 people worldwide have succumbed to the infection. Reports have shown that some comorbidities and illnesses raise the risk of getting infected and also influence the severity of the disease. Having a compromised immune system can also drastically raise the risk of getting COVID-19.

21 Apr 2020